J. Lobos

发表

Hipertensión arterial y polı́tica de salud en España Hypertension and health policy in Spain

J. Banegas, L. Ruilope, J. Segura, 2009 .

Relative value of the Ankle‐Brachial Index of intermittent claudication

J. González-Porras, F. Lozano, J. March, 2014, International journal of clinical practice.

Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU.

F. Arikan, A. Gómez, J. Ferreiro, 2018, Revista espanola de cardiologia.

[European Guidelines on Cardiovascular Disease Prevention in Clinical Practice: CEIPC 2008 Spanish adaptation].

P. Conthe, S. Sans, F. Álvaro, 2008, Revista espanola de salud publica.

[SEN-SEMFYC consensus document on chronic kidney disease].

J. Górriz, J. Lobos, F. Álvarez Guisasola, 2008, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Prevalence of Stable Angina in Spain. Results of the OFRECE Study.

F. Chorro, J. Muñiz, M. Anguita, 2013, Revista espanola de cardiologia.

Blood pressure control in anticoagulated patients with hypertension and atrial fibrillation

V. Barrios, C. Escobar, J. Lobos, 2017, Blood pressure.

Validation of the Walking Impairment Questionnaire for Spanish patients.

J. González-Porras, F. Lozano, J. March, 2013, VASA. Zeitschrift fur Gefasskrankheiten.

SAMe-TT2R2 Score: Useful in All Patients With Nonvalvular Atrial Fibrillation?

V. Barrios, C. Escobar, J. Lobos, 2016, Revista espanola de cardiologia.

Self-management of vitamin K antagonists is more cost-effective than dabigatran for stroke prevention in non-valvular atrial fibrillation in Spain. Response.

J. González-Juanatey, J. Reverter, V. Becerra, 2013, Revista espanola de cardiologia.

Control of Anticoagulation With Warfarin or Acenocoumarol in Spain. Do They Differ?

V. Barrios, C. Escobar, J. Lobos, 2015, Revista espanola de cardiologia.

Degree of Anticoagulation Control in Patients With Atrial Fibrillation in Spain: Need to Minimize Biases and Contextualize Results. Response by Anguita Sánchez et al.

V. Barrios, C. Escobar, J. Lobos, 2016 .

Degree of Anticoagulation Control in Patients With Atrial Fibrillation in Spain: Need to Minimize Biases and Contextualize Results. Response Barrios et al.

V. Barrios, C. Escobar, J. Lobos, 2016, Revista espanola de cardiologia.

[Evaluation and management of hypertension in Spain. A consensus guide].

J. Banegas, L. Ruilope, A. de la Sierra, 2008, Medicina clinica.

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

Cost-effectiveness analysis of rosuvastatin vs generic atorvastatin in Spain

V. Barrios, M. Brosa, M. Capel, 2012, Journal of medical economics.

Prevalence of atrial fibrillation in Spain. OFRECE study results.

F. Chorro, J. Muñiz, M. Anguita, 2014, Revista espanola de cardiologia.

Cost-effectiveness of dabigatran for stroke prevention in non-valvular atrial fibrillation in Spain.

J. Álvarez-Sabín, A. Martínez-Rubio, J. González-Juanatey, 2012, Revista espanola de cardiologia.

Diabetes mellitus and intermittent claudication: a cross-sectional study of 920 claudicants

J. González-Porras, F. Lozano, J. March, 2014, Diabetology & Metabolic Syndrome.

Differences between women and men with intermittent claudication: a cross-sectional study.

J. González-Porras, F. Lozano, J. March, 2014, Journal of women's health.

Implementation of Spanish adaptation of the European guidelines on cardiovascular disease prevention in primary care

A. Castellanos, S. Sans, C. Brotons, 2013, BMC Family Practice.

Self-administered versus interview-based questionnaires among patients with intermittent claudication: Do they give different results? A cross-sectional study

J. González-Porras, F. Lozano, J. March, 2016, Sao Paulo medical journal = Revista paulista de medicina.

Prevalence of stable angina in Spain. Results of the OFRECE study

F. Chorro, J. Muñiz, M. Anguita, 2013 .

Intra-arterial chemotherapy for retinoblastoma treatment in Chile: experience and results 2013-2020.

J. Lobos, V. Pérez, D. Ossandón, 2020, Archivos de la Sociedad Espanola de Oftalmologia.

Consensus document for the use of the Polypill in the secondary prevention of cardiovascular disease

C. Suárez, G. Barón-Esquivias, J. González-Juanatey, 2017 .

A Step Ahead in Secondary Prevention of Cardiovascular Risk. Consensus Document on Clinical Use of the Polypill.

J. González-Juanatey, J. Llisterri, B. Abarca, 2016, Revista espanola de cardiologia.

Natriuretic Peptides: Consensus Call for Use.

A. Bayés‐Genís, J. González-Juanatey, J. Casademont, 2016, Revista espanola de cardiologia.

Consensus document and recommendations on the use of natriuretic peptides in clinical practice

Jordi Casademont, Antoni Bayes-Genis, Domingo A. Pascual-Figal, 2016 .

[The condition of the cardiovascular prevention in Spain].

S. Sans, C. Brotons, C. de Pablo, 2014, Medicina clínica (Ed. impresa).

Anticoagulation Control in Patients With Nonvalvular Atrial Fibrillation Attended at Primary Care Centers in Spain: The PAULA Study.

V. Barrios, C. Escobar, J. Lobos, 2015, Revista espanola de cardiologia.

F. Arikan, A. Gómez, J. Ferreiro, 2018, Revista espanola de cardiologia.

Anticoagulation Control in Patients With Nonvalvular Atrial Fibrillation Attended at Primary Care Centers in Spain: The PAULA Study.

V. Barrios, C. Escobar, J. Lobos, 2015, Revista espanola de cardiologia.

Intra-arterial chemotherapy for retinoblastoma treatment in Chile: experience and results 2013-2020.

X. Stetcher, J. Lobos, D. Ossandón, 2020, Archivos de la Sociedad Espanola de Oftalmologia.